Home › Journal › No. 2168 › Class 5 › AMOXICAM LB 625

AMOXICAM LB 625 · application 5437599, class 5

Advertised in Trade Marks Journal No. 2168 on 5 August 2024. Opposition window closes 5 December 2024.

AMOXICAM LB 625

Application
5437599 · filed 6 May 2022 · Mumbai office
Class
Class 5: Pharmaceuticals and health
Applicant
Leodius Pharmaceuticals PVT. LTD. (Company)
Use claimed
Proposed to be used
Advertised
Trade Marks Journal No. 2168, 5 August 2024

Goods or services claimed

MEDICINAL AND PHARMACEUTICAL PREPARATIONS

Opposition window closes 5 December 2024. This mark has passed examination and is advertised so that anyone with an earlier right can object. A notice of opposition (Form TM-O) may be filed until that date; after it, the application proceeds to registration and the mark can only be challenged by rectification. Whether an opposition is worth filing depends on how close the marks are and whether the goods overlap: see how opposition works.

What "advertised" means for AMOXICAM LB 625

Advertised is not registered. The Registry examined the application, found no bar (or the applicant overcame the objection), and published it. Registration follows only if no opposition is filed within four months, or if an opposition fails. Until the certificate issues, the applicant may use ™ but not ®. Our guide to trademark status meanings explains each stage, and how long registration takes gives realistic timelines.

Source and corrections. Details are reproduced as advertised by the Registrar of Trade Marks in the Trade Marks Journal (a public record) and may contain errors of transcription. Applicants may ask for a correction or removal of their entry by writing to mehak@trademarkindia.pro. This page is information, not legal advice and not a solicitation.

WhatsApp us